Targeting EZH2 for Cancer Therapy: Progress and Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1875-5550|16|6|559-570

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.16, Iss.6, 2015-09, pp. : 559-570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer

By Verma Sharad K   Knight Steven D  

Future Medicinal Chemistry, Vol. 5, Iss. 14, 2013-09 ,pp. : 1661-1670

Future Science

Access to resources Recommend Favorite

Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer

By  

Current Molecular Imaging, Vol. 2, Iss. 2, 2013-07 ,pp. : 120-129

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting autophagy to enhance oncolytic virus-based cancer therapy

By Meng Songshu  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 6, 2013-08 ,pp. : 863-873

Informa Healthcare

Access to resources Recommend Favorite

T-cell receptor gene therapy for cancer: the progress to date and future objectives

By Thomas Sharyn   Hart Daniel P   Xue Shao-An   Cesco-Gaspere Michela   Stauss Hans J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 8, 2007-08 ,pp. : 1207-1218

Informa Healthcare

Access to resources Recommend Favorite

Targeting the SH2 Domain-Containing Inositol Phosphatase (SHIP) for Therapy

By  

Current Enzyme Inhibition, Vol. 5, Iss. 3, 2009-01 ,pp. : 153-162

Bentham Science Publishers

Access to resources Recommend Favorite